Mengistu Andinet M, Wolf Michael W, Boldt Joachim, Röhm Kerstin D, Lang Johannes, Piper Swen N
Department of Anesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen, Ludwigshafen, Germany.
J Cardiothorac Vasc Anesth. 2008 Feb;22(1):40-6. doi: 10.1053/j.jvca.2007.02.015. Epub 2007 May 23.
Impaired hemostasis of multiple etiologies are often present in patients undergoing cardiopulmonary bypass (CPB) surgery. Platelet dysfunction is considered to be important in the early postoperative period. Therefore, a new whole-blood platelet function analyzer was compared with thromboelastography in predicting postoperative hemostatic outcomes as measured by blood loss and blood product use.
Prospective study.
Teaching hospital.
The study enrolled 54 patients scheduled for coronary artery bypass surgery with CPB.
Coagulation and platelet function were assessed preoperatively, after CPB, at 3 hours, and at 24 hours after surgery by using thromboelastography and impedance aggregometry. Patients were divided into a transfused and nontransfused group on the basis of postoperative transfusion requirements. Postoperative blood loss and requirements of blood transfusions were documented until 24 hours postoperatively.
Twenty-five patients (46%) received postoperative blood transfusions. Impaired hemostasis occurred after CPB detected by thromboelastography (p < 0.01) and impedance aggregometry (p < 0.01). In contrast to thromboelastography, preoperative adenosine diphosphate-mediated aggregometry correlated with postoperative requirements for blood transfusion (Spearman r = -0.302, p < 0.05) and was significantly lower in patients receiving allogeneic blood transfusion compared with nontransfused patients (p < 0.05). Neither aggregometry nor thromboelastography was correlated with postoperative blood loss.
Impedance aggregometry as well as thromboelastography are able to detect impaired hemostasis after CPB. In contrast to thromboelastography, aggregometry using a new whole-blood aggregometer identified patients with a reduced risk for postoperative transfusion requirements.
接受体外循环(CPB)手术的患者常存在多种病因导致的止血功能受损。血小板功能障碍被认为在术后早期很重要。因此,将一种新型全血血小板功能分析仪与血栓弹力图在预测术后止血结局(通过失血量和血液制品使用情况衡量)方面进行了比较。
前瞻性研究。
教学医院。
该研究纳入了54例计划行冠状动脉搭桥手术并接受CPB的患者。
术前、CPB后、术后3小时和24小时,采用血栓弹力图和阻抗聚集法评估凝血和血小板功能。根据术后输血需求将患者分为输血组和未输血组。记录术后24小时内的失血量和输血需求。
25例患者(46%)接受了术后输血。血栓弹力图(p < 0.01)和阻抗聚集法(p < 0.01)检测到CPB后止血功能受损。与血栓弹力图不同,术前二磷酸腺苷介导的聚集法与术后输血需求相关(Spearman r = -0.302,p < 0.05),并且接受异体输血的患者与未输血患者相比显著降低(p < 0.05)。聚集法和血栓弹力图均与术后失血量无关。
阻抗聚集法以及血栓弹力图能够检测CPB后的止血功能受损。与血栓弹力图不同,使用新型全血聚集仪的聚集法识别出术后输血需求风险降低的患者。